NCT05984940

Brief Summary

The use of bioceramics materials as root canal fillings in endodontics is gaining traction due to their excellent biocompatibility, antibacterial and sealing abilities. They are dispensed in the form of sealers and cements to be used with gutta-percha or mixed with liquids to form a paste. Recently, Ortho MTA (BioMTA®) cement is clinically available as a root filling material, without the need for gutta-percha. The purpose of this randomized controlled clinical trial is to compare clinical outcome between the novel Ortho MTA (BioMTA®) and the conventional gutta-percha with bioceramic sealer, when used as obturating materials in root canal treatment. This research aims to compare the healing outcome of infected teeth treated by root canal treatment and root-filled using MTA cement (Ortho MTA, BioMTA® Seoul Korea) or bioceramic sealer (AH Plus® Bioceramic Sealer (Dentsply). The sealer can be used alone or in combination with gutta-percha obturating cones, injected gutta-percha material or core-carriers master cones. In vitro studies have demonstrated the capability of MTA to generate hydroxyapatite precipitates that penetrate into dentinal tubules.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 9, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

September 21, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 28, 2024

Status Verified

September 1, 2023

Enrollment Period

1.3 years

First QC Date

July 12, 2023

Last Update Submit

August 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary Objectives (Change in baseline periapical lesion size at 6 month and 12 month)

    Change in baseline periapical lesion size at 6 month and 12 month

    6, 12 months

Secondary Outcomes (1)

  • Secondary Objectives (Change in baseline post-operative pain at Day 1, Day 3 and Day 7 post treatment)

    1, 3, 7 days

Study Arms (2)

GP and AH Plus sealer

ACTIVE COMPARATOR

Root canal obturation using gutta percha and AH Plus® bioceramic sealer.

Device: GP and AH Plus sealer

Ortho MTA

EXPERIMENTAL

Root canal obturation using Ortho MTA cement.

Device: Ortho MTA cement

Interventions

Ortho MTA has a fine granularity for only 2 microns. It penetrates into dental tubules and fuses itself to the surface where it is applied. In addition, it prevents micro-leakage by forming an interfacing layer of hydroxyapatite (Hap) between the OrthoMTA and the canal wall.

Ortho MTA

AH Plus Sealer is a calcium silicate-based root canal sealer. Tricalcium Silicate interacts with body fluids to release calcium and hydroxide ions that promote hydroxyapatite (HA) formation.

GP and AH Plus sealer

Eligibility Criteria

Age21 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A preoperative periapical radiograph will be required for diagnosis.
  • Subjects at least 21 years old to 95 years old.
  • Medically healthy
  • In a patient with multiple teeth requiring root canal treatment, only 1 tooth from each side will be included and selected at random.
  • Tooth requiring root canal treatment presenting with periapical radiolucency.

You may not qualify if:

  • Patients below 21 years old.
  • Pregnant women.
  • Patients with autoimmune disease and uncontrolled diabetes.
  • Teeth with periodontal probing depth 5mm or more.
  • Incomplete root formation that is detected radiographically.
  • Cracked teeth.
  • Teeth are deemed to have poor restorative prognosis.
  • Teeth with adjacent teeth on the same side that require root canal treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National University Hospital, Singapore

Singapore, 119074, Singapore

RECRUITING

MeSH Terms

Conditions

Dental Pulp Diseases

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2023

First Posted

August 9, 2023

Study Start

September 21, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

August 28, 2024

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations